EG7 - Valuable “Free-to-Play Add-On”
2020-09-18 08:00:00
Redeye raises its valuation due to an expected value-adding acquisition. Despite we estimate a postponed Stock Catalyst in 2020 namely the release of the self-developed “EvilvEvil” we project higher than previously estimated revenues and profits thanks to the “Free-to-Play Add-On”.
Read more and download the Research Update
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/